152 related articles for article (PubMed ID: 22986704)
1. Prevalence of human leukocyte antigen-B*5701 among HIV-infected children in Thailand and Cambodia: implications for abacavir use.
Puthanakit T; Bunupuradah T; Kosalaraksa P; Vibol U; Hansudewechakul R; Ubolyam S; Suwanlerk T; Kanjanavanit S; Ngampiyaskul C; Wongsawat J; Luesomboon W; Vonthanak S; Ananworanich J; Ruxrungtham K;
Pediatr Infect Dis J; 2013 Mar; 32(3):252-3. PubMed ID: 22986704
[TBL] [Abstract][Full Text] [Related]
2. HLA- B*5701 Allele in HIV-infected Indian Children and its Association with Abacavir Hypersensitivity.
Manglani MV; Gabhale YR; Lala MM; Sekhar R; More D
Indian Pediatr; 2018 Feb; 55(2):140-141. PubMed ID: 29242412
[TBL] [Abstract][Full Text] [Related]
3. Should HLA-B*5701 screening be performed in every ethnic group before starting abacavir?
Park WB; Choe PG; Song KH; Lee S; Jang HC; Jeon JH; Park SW; Park MH; Oh MD; Choe KW
Clin Infect Dis; 2009 Feb; 48(3):365-7. PubMed ID: 19115972
[TBL] [Abstract][Full Text] [Related]
4. HLA-B*57:01 allele prevalence in HIV-infected North American subjects and the impact of allele testing on the incidence of abacavir-associated hypersensitivity reaction in HLA-B*57:01-negative subjects.
Small CB; Margolis DA; Shaefer MS; Ross LL
BMC Infect Dis; 2017 Apr; 17(1):256. PubMed ID: 28399804
[TBL] [Abstract][Full Text] [Related]
5. Abacavir adverse reactions related with HLA-B*57: 01 haplotype in a large cohort of patients infected with HIV.
Quiros-Roldan E; Gardini G; Properzi M; Ferraresi A; Carella G; Marchi A; Malagoli A; Focà E; Castelli F
Pharmacogenet Genomics; 2020 Oct; 30(8):167-174. PubMed ID: 32453265
[TBL] [Abstract][Full Text] [Related]
6. Association between presence of HLA-B*5701, HLA-DR7, and HLA-DQ3 and hypersensitivity to HIV-1 reverse-transcriptase inhibitor abacavir.
Mallal S; Nolan D; Witt C; Masel G; Martin AM; Moore C; Sayer D; Castley A; Mamotte C; Maxwell D; James I; Christiansen FT
Lancet; 2002 Mar; 359(9308):727-32. PubMed ID: 11888582
[TBL] [Abstract][Full Text] [Related]
7. Frequency of HLA B*5701 allele carriers in abacavir treated-HIV infected patients and controls from northeastern Brazil.
Crovella S; Biller L; Santos S; Salustiano A; Brandao L; Guimaraes R; Segat L; Lima Filho JL; Arraes LC
Clinics (Sao Paulo); 2011; 66(8):1485-8. PubMed ID: 21915505
[No Abstract] [Full Text] [Related]
8. Prevalence of HLA-B*57:01 allele in Argentinean HIV-1 infected patients.
Moragas M; Belloso WH; Baquedano MS; Gutierrez MI; Bissio E; Larriba JM; Fay F; Aulicino P; Gurevich JM; Yaunguzian MF; Maldonado AC; Falistocco C; Sen L; Mangano A
Tissue Antigens; 2015 Jul; 86(1):28-31. PubMed ID: 25922880
[TBL] [Abstract][Full Text] [Related]
9. Incidence of abacavir hypersensitivity and its relationship with HLA-B*5701 in HIV-infected patients in Taiwan.
Sun HY; Hung CC; Lin PH; Chang SF; Yang CY; Chang SY; Chang SC
J Antimicrob Chemother; 2007 Sep; 60(3):599-604. PubMed ID: 17631508
[TBL] [Abstract][Full Text] [Related]
10. Absence of human leukocyte antigen-B*57:01 amongst patients on antiretroviral therapy in Nigeria: Implications for use of abacavir.
Agbaji OO; Akanbi MO; Otoh I; Agaba PA; Akinsola R; Okolie V; Ugoagwu PO; Babadoko AA; Adediran A; Finomo FO; Abah JO; Muktar HM; Akanmu AS
Niger Postgrad Med J; 2019; 26(4):195-198. PubMed ID: 31621657
[TBL] [Abstract][Full Text] [Related]
11. Human leukocyte antigen (HLA) and pharmacogenetics: screening for HLA-B*57:01 among human immunodeficiency virus-positive patients from southern Alberta.
Berka N; Gill JM; Liacini A; O'Bryan T; Khan FM
Hum Immunol; 2012 Feb; 73(2):164-7. PubMed ID: 22197535
[TBL] [Abstract][Full Text] [Related]
12. HLA-B*5701 frequency in Chilean HIV-infected patients and in general population.
Poggi H; Vera A; Lagos M; Solari S; Rodríguez P L; Pérez CM
Braz J Infect Dis; 2010; 14(5):510-2. PubMed ID: 21221482
[TBL] [Abstract][Full Text] [Related]
13. Prospective HLA-B*5701 screening and abacavir hypersensitivity: a single centre experience.
Waters LJ; Mandalia S; Gazzard B; Nelson M
AIDS; 2007 Nov; 21(18):2533-4. PubMed ID: 18025891
[TBL] [Abstract][Full Text] [Related]
14. HLA-B*5701 screening for hypersensitivity to abacavir.
Mallal S; Phillips E; Carosi G; Molina JM; Workman C; Tomazic J; Jägel-Guedes E; Rugina S; Kozyrev O; Cid JF; Hay P; Nolan D; Hughes S; Hughes A; Ryan S; Fitch N; Thorborn D; Benbow A;
N Engl J Med; 2008 Feb; 358(6):568-79. PubMed ID: 18256392
[TBL] [Abstract][Full Text] [Related]
15. HLA-B*5701 genetic screening prior to abacavir prescription in Georgia.
Dvali N; Chkhartishvili N; Sharvadze L; Karchava M; Tsertsvadze T
Georgian Med News; 2010 Dec; (189):16-20. PubMed ID: 21252404
[TBL] [Abstract][Full Text] [Related]
16. Prevalence of HLA-B*5701 in HIV-infected patients in Spain (results of the EPI Study).
Arrizabalaga J; Rodriguez-Alcántara F; Castañer JL; Ocampo A; Podzamczer D; Pulido F; Riera M; Sanz J; Pascual-Bernaldez M; Dal-Re R;
HIV Clin Trials; 2009; 10(1):48-51. PubMed ID: 19362996
[TBL] [Abstract][Full Text] [Related]
17. HLA-B*5701 genetic screening among HIV-1 infected patients in Hong Kong: is this a practical approach in Han-Chinese?
To SW; Chen JH; Wong KH; Chan KC; Tsang OT; Yam WC
Int J STD AIDS; 2013 Jan; 24(1):50-2. PubMed ID: 23512513
[TBL] [Abstract][Full Text] [Related]
18. Prospective epidemiological study of the prevalence of human leukocyte antigen (HLA)-B*5701 in HIV-1-infected UK subjects.
Orkin C; Sadiq ST; Rice L; Jackson F;
HIV Med; 2010 Mar; 11(3):187-92. PubMed ID: 19780860
[TBL] [Abstract][Full Text] [Related]
19. Distribution of HLA-B alleles in a Ugandan HIV-infected adult population: NORA pharmacogenetic substudy of DART.
Munderi P; Snowden WB; Walker AS; Kityo C; Mosteller M; Kabuye G; Thoofer NK; Ssali F; Gilks CF; Hughes AR;
Trop Med Int Health; 2011 Feb; 16(2):200-4. PubMed ID: 21091860
[TBL] [Abstract][Full Text] [Related]
20. Prospective genetic screening decreases the incidence of abacavir hypersensitivity reactions in the Western Australian HIV cohort study.
Rauch A; Nolan D; Martin A; McKinnon E; Almeida C; Mallal S
Clin Infect Dis; 2006 Jul; 43(1):99-102. PubMed ID: 16758424
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
